Clinical application of Ca2 (+) -antagonist for prevention and treatment of cerebral vasospasm
Kyoi, K.; Utsumi, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 47(8): 1831-1836
1989
ISSN/ISBN: 0047-1852 PMID: 2685399 Document Number: 335511
Document emailed within 1 workday
Related Documents
Nishizawa, Y. 1993: The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 389-396Majchrzak, H.; Lech, A.; Kopera, M.; Gajos, L.; Dragan, T.; Ladziński, P. 1995: Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm Neurologia i Neurochirurgia Polska 29(3): 379-387
Asano, T.; Hidaka, H. 1990: New pharmacological strategies in vascular diseases: a novel intracellular calcium antagonist, HA1077 (AT-877) and cerebral vasospasm Methods and Findings in Experimental and Clinical Pharmacology 12(6): 443-448
Yanaka, K.; Kamezaki, T.; Fujita, K.; Kato, N.; Nagase, S.; Hirayama, A.; Asakawa, H.; Yamazaki, T.; Nose, T. 2001: Prevention of delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage Drugs of Today 37(8): 573-578
Niizuma, H.; Kwak, R.; Ohi, T.; Katakura, R.; Mizoi, K.; Suzuki, J. 1978: The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl) No Shinkei Geka. Neurological Surgery 6(8): 749-755
Mutoh, T.; Ishikawa, T.; Yasui, N. 2009: Application of the FloTrac arterial pressure-based continuous cardiac output monitor to dobutamine-induced hyperdynamic therapy for cerebral vasospasm after subarachnoid hemorrhage No Shinkei Geka. Neurological Surgery 37(11): 1085-1093
Giannotta, S.L.; McGillicuddy, J.E.; Kindt, G.W. 1977: Diagnosis and treatment of postoperative cerebral vasospasm Surgical Neurology 8(4): 286-290
Newell, D.W.; Eskridge, J.; Mayberg, M.; Grady, M.S.; Lewis, D.; Winn, H.R. 1992: Endovascular treatment of intracranial aneurysms and cerebral vasospasm Clinical Neurosurgery 39: 348-360
Krylov, V.V.; Lebedev, V.V.; Shelkovskiĭ, V.N.; Kuksova, N.S.; Zakharov, A.G. 1987: Surgical treatment of cerebral aneurysms complicated by vasospasm in the acute period Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 2: 3-8
Sakaki, T.; Tanikake, T.; Kyoi, K.; Utsumi, S.; Kikuchi, H.; Oshima, M.; Hiasa, Y.; Murata, Y. 1980: A histopathological study of the brain of patients who died of cerebral vasospasm after rupture of cerebral aneurysm No Shinkei Geka. Neurological Surgery 8(9): 845-850
Desbordes, J.M.; Ades, P.E.; Guggiari, M. 1989: Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 30(7): 438-440
Ciplea, A.G.; Bock, P.R. 1976: Cardioprotection by oral application of the calcium antagonist fendiline. Prevention of isoproterenol-induced myocardial necroses in rats Arzneimittel-Forschung 26(10): 1819-1826
Miyagi, K.; Ishijima, B.; Sato, F.; Kubota, T.; Sakuraya, N. 1984: Indication for, the method of, and result of the prophylactic use of barbiturate therapy (B-therapy) against cerebral infarct from cerebral arterial vasospasm due to ruptured aneurysm No Shinkei Geka. Neurological Surgery 12(3 Suppl): 303-310
Flamm, E.S.; Kim, J.; Lin, J.; Ransohoff, J. 1974: Phosphodiesterase inhibitors and cerebral vasospasm Transactions of the American Neurological Association 99: 137-140
Haberl, R.L.; Villringer, A. 1990: Hypertensive-hypervolemic therapy in cerebral vasospasm Der Nervenarzt 61(12): 749-751
Türker, R.K.; Egemen, N.; Deda, H. 1989: Cerebral vasospasm: resolution by iloprost, nocloprost and UK 38 485 Progress in Clinical and Biological Research 301: 205-209
Sakai, T.; Okada, J.; Hara, M.; Ogashiwa, M.; Takeuchi, K. 1985: Red cell deformability in patients with cerebral vasospasm International Journal of Clinical Pharmacology Therapy and Toxicology 23(2): 79-82
Zuccarello, M. 2001: Endothelin: the "prime suspect" in cerebral vasospasm Acta Neurochirurgica. Suppl 77: 61-65
Ono, S.; Date, I.; Ohmoto, T. 2001: Linkage of gene expression with cerebral vasospasm No Shinkei Geka. Neurological Surgery 29(7): 589-602
Ishizaki, T.; Momota, H.; Kuwahara, K.; Tanooka, A.; Morimoto, S. 1999: A case of symptomatic traumatic cerebral vasospasm associated with hyponatremia No Shinkei Geka. Neurological Surgery 27(11): 1031-1036